EVOQ REMEDIES-MT Balance Sheet Annual

BSE: 543500 | NSE: - | ISIN: INE0JVD01011 | Sector: Biotechnology & Drugs

7.33 - (-)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	0.12	0.15	3.09	0.03
Cashand Short Term Investments	0.12	0.15	3.09	0.03
Accounts Receivable- Trade Net	1.74	17.22	25.40	6.84
Total Receivables Net	33.28	25.08	29.13	7.71
Total Inventory	3.13	2.03	0.78	0.15
Other Current Assets Total	0.32	7.62	0.32	0.16
Total Current Assets	36.85	34.89	33.33	8.05
Property/ Plant/ Equipment Total- Net	0.01	0.01	0.00	0.00
Note Receivable- Long Term	0.00	0.00	0.00	0.00
Other Long Term Assets Total	0.00	0.00	0.00	0.00
Total Assets	36.86	34.90	33.33	8.05
Accounts Payable	3.28	-0.54	1.21	6.78
Notes Payable/ Short Term Debt	4.24	9.58	0.00	0.00
Other Currentliabilities Total	4.10	1.07	0.80	0.52
Total Current Liabilities	11.62	10.11	10.17	7.30
Long Term Debt	0.00	0.00	0.00	0.00
Total Long Term Debt	0.00	0.00	0.00	0.00
Total Debt	4.24	9.58	8.16	0.00
Deferred Income Tax	0.00	0.00	-	-
Other Liabilities Total	0.00	-	-	-
Total Liabilities	11.62	10.11	10.17	7.30
Common Stock Total	13.60	13.60	13.60	0.01
Retained Earnings( Accumulated Deficit)	11.64	11.19	9.57	0.73
Other Equity Total	0.00	-	-	-
Total Equity	25.24	24.79	23.17	0.74
Total Liabilities Shareholders' Equity	36.86	34.90	33.33	8.05
Total Common Shares Outstanding	1.36	1.36	1.36	1.36
Tangible Book Valueper Share Common Eq	18.56	18.22	17.03	0.55
Current Portof LT Debt/ Capital Leases	-	-	8.16	0.00